2016 Publications

  1. Reeve J, Chang J, Salazar IDR, Lopez MM, and Halloran PF. Using molecular phenotyping to guide improvements in the histologic diagnosis of T cell-mediated rejection. Am J Transplant 2016;(4):1183-92.
  2. Halloran, PF, Lopez MM, and Pereira AB. Identifying sub-phenotypes of antibody-mediated rejection in kidney transplants. Am J Transplant 2016;(3):908-20.
  3. Venner JM, Famulski KS, Reeve J, Chang J and Halloran PF. Relationships among injury, fibrosis, and time in human kidney transplants. Journal of Clinical Investigation Insight 2016;1(1):e85323.
  4. Halloran PF, Famulski KS and Reeve J. Molecular assessment of disease states in kidney transplant biopsies. Nature Reviews Nephrology 2016;12(9):534-548.
  5. Aubert O, Loupy A, Hidalgo LG, Duong Van-Huyen JP, Higgins S, Viglietti D, Jouven X, Glotz D, Legendre C, Lefaucheur C and Halloran PF. Antibody-mediated rejection due to pre-existing vs. de novo DSA in kidney allograft recipients. J Am Soc Nephrol 2016;28(6):1912-1923.
  6. Wadstrom J, Ericzon BG, Halloran PF, Bechstein WO, Opelz G, Seron D, Grinyo J, Loupy A, Kuypers D, Mariat C, Clanton M, Jardine A, Guirado L, Fellstrom B, O'Grady J, Pirenne J, O'Leary JG, Aluviahare V, Trunecka P, Baccarani U, Neuberger J, Soto-Gutierrez A, Geissler EK, Metzger M and Gray M. Advancing Transplantation: New Questions, New Possibilities in Kidney and Liver Transplantation. Transplantation 2016;101(2S):S1-S41.